Lung Cancer Trial, Not Yet Recruiting NCT07521618 Sponsor: Guangzhou Medical University Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT07521618
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults aged 18 or older, of any gender.
  • People with a high-risk lung nodule or tumour that measures 3 cm or less at its widest point.
  • People whose lung lesion has been assessed as suitable for diagnosis and treatment using a navigation-guided bronchoscopy approach (a procedure that uses a thin tube guided through the airways).
  • People who are not eligible for surgery, or who have declined surgery or radiotherapy, and who agree to a primary ablation treatment (a procedure that destroys the tumour) and have given written consent to participate.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with widespread lesions spread across both lungs that are not suitable for ablation treatment.
  • People for whom bronchoscopy is medically inadvisable, or who are unable to tolerate or cooperate with the procedure.
  • People with a serious tendency to bleed or a blood-clotting disorder that cannot be corrected, including specific blood test results outside acceptable ranges (confirm with trial site), or a platelet count below 70×10⁹/L, or who have stopped blood-thinning or anti-clotting medication less than one week before the procedure (with an exception for certain low-dose preventive heparin injections).
  • People with severely reduced lung function, specifically where a breathing capacity measurement falls below 40% of the expected level (confirm with trial site).
  • People with other cancers that have spread widely throughout the body, or whose life expectancy is less than 3 months.
  • People in poor overall health, including those with widespread cancer spread, serious infection, high fever, inflammation around the lesion from infection or radiation, significant wasting of the body, severe failure of major organs, severe anaemia, or nutritional or metabolic problems that cannot be corrected.
  • People with a general health and activity score above 2 on a standard medical scale used to measure how much a condition limits daily activities (confirm with trial site).
  • People whose target lesion has been treated with radiotherapy within the past 6 months.
  • People with active hepatitis B, active hepatitis C, known HIV, or other active infections that the trial doctor considers would interfere with treatment.
  • People with a history of epilepsy, psychosis, or significant cognitive impairment.
  • People who are pregnant or breastfeeding, or people of any gender who are planning to conceive a child during the trial period.
  • People who the trial investigator considers unsuitable for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If this is close to home

This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.

  • Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
  • Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
  • Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
  • Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
  • Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14

Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.

Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Phone: 02081566640

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Guangzhou Medical University
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
31 December 2026

Primary endpoints

Integrated completion rate of detection, sampling and treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov